Hematopoietic and Lymphoid Cell NeoplasmNCT06062901
An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors
A study testing Educational Intervention, Interview and Survey Administration in people with Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, run by Ohio State University Comprehensive Cancer Center at 1 site in United States.
Trial summary
This clinical trial utilizes the Project Extension for Community Healthcare Outcomes (ECHO) model to recruit, train, and support community healthcare providers in cancer survivorship best practices. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
- What is being tested?
- Educational Intervention, Interview and Survey Administration
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Sep 2021to 19 Sep 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Providers from The James Cancer Network (consists of five community sites in Ohio: St. Rita's Memorial Center, Memorial Health, Madison Health, Wooster Community Hospital, and Clinton Memorial Hospital)
- Eligible participants will include registered nurses, advanced practice registered nurses, physician assistants, nutritionists, radiation oncologists and oncologists
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
United States1 site
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210
About this study
Official title: Survivorship ECHO Project
This clinical trial utilizes the Project Extension for Community Healthcare Outcomes (ECHO) model to recruit, train, and support community healthcare providers in cancer survivorship best practices. Cancer survivors have distinct medical needs and are more likely to report being in poor or fair overall health compared to those who do not report a history of cancer. There is a lack of educational opportunities focused on survivorship care for health providers. Although progress has been made with the development of survivorship guidelines, physicians continue to express barriers to addressing concerns of cancer survivors. This study is to utilize a Survivorship ECHO education intervention to assess its effects on provider knowledge and comfort with survivorship guidelines as well as greater adherence to guideline concordant breast cancer survivorship care recommendations.
Read the detailed description
PRIMARY OBJECTIVES:
- Determine the effectiveness of the Survivorship ECHO's platform by assessing provider knowledge of cancer survivorship best practices using pre- and post-enrollment surveys.
II. Evaluate implementation of survivorship best practices into clinical practice and documentation after enrollment in our Survivorship ECHO.
OUTLINE:
Participants attend 6 sessions of Survivorship ECHO educational intervention over 1 hour each, every 2 weeks for 12 weeks. Participants may optionally participate in a one-on-one interview to give feedback about the sessions over 30 minutes.
- Being tested
- Educational Intervention, Interview, Survey Administration
- Medical subject headings
- Hematologic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Educational InterventionOther
Also called Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Receive educational intervention
InterviewOther
Participate in one-on-one interview
Survey AdministrationOther
Ancillary studies
| Study group | Role | What they receive |
|---|---|---|
| Health services research (Survivorship ECHO) | Experimental | Participants attend 6 sessions of Survivorship ECHO educational intervention over 1 hour each, every 2 weeks for 12 weeks. Participants may optionally participate in a one-on-one interview to give feedback about the sessions over 30 minutes. Receives: Other: Educational Intervention; Other: Interview; Other: Survey Administration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in level of understanding in key survivorship knowledge areas
Includes knowledge on surveillance, late and long-term effects of chemotherapy, health promotion, disease prevention and psychosocial evaluation and support. A Likert survey will assess provider comfort and knowledge with core cancer survivorship competencies with higher scores associated with higher levels of knowledge and comfort.
Measured: Baseline up to study completion, typically 1 year
Met and unmet needs
Content, participant needs, and aspects of delivering the Survivorship ECHO platform explored using qualitative analysis.
Measured: Up to study completion, typically 1 year
Acceptability of current structure
Content, participant needs, and aspects of delivering the Survivorship ECHO platform explored using qualitative analysis.
Measured: Up to study completion, typically 1 year
Barriers to accessing ECHO
Content, participant needs, and aspects of delivering the Survivorship ECHO platform explored using qualitative analysis.
Measured: Up to study completion, typically 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2023
- Study start17 Sep 2021
- Primary completion19 Sep 2023
- Study completion19 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hematopoietic and Lymphoid Cell NeoplasmStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 28 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ashley Davenport, Ohio State University Comprehensive Cancer Center
- Investigators
- Ashley Davenport, MD, Principal investigator, Ohio State University Comprehensive Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06062901
- Sponsor's protocol ID
- OSU-21149
- Other IDs
- NCI-2021-06471
- Status last verified
- Dec 2025
- First submitted
- 12 Sep 2023
- Last updated
- 12 Dec 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Survivorship ECHO Project
- ClinicalTrials.gov ID
- NCT06062901
- Acronym / sponsor ID
- OSU-21149
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 28 participants (actual)
- Lead sponsor
- Ohio State University Comprehensive Cancer CenterUniversity, hospital or other
- Study start
- 17 Sep 2021 (actual)
- Primary completion
- 19 Sep 2023 (actual)
- Study completion
- 19 Sep 2023 (actual)
- First posted
- 2 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This clinical trial utilizes the Project Extension for Community Healthcare Outcomes (ECHO) model to recruit, train, and support community healthcare providers in cancer survivorship best practices. Cancer survivors have distinct medical needs and are more likely to report being in poor or fair overall health compared to those who do not report a history of cancer. There is a lack of educational opportunities focused on survivorship care for health providers. Although progress has been made with the development of survivorship guidelines, physicians continue to express barriers to addressing concerns of cancer survivors. This study is to utilize a Survivorship ECHO education intervention to assess its effects on provider knowledge and comfort with survivorship guidelines as well as greater adherence to guideline concordant breast cancer survivorship care recommendations.
Detailed description
PRIMARY OBJECTIVES:
- Determine the effectiveness of the Survivorship ECHO's platform by assessing provider knowledge of cancer survivorship best practices using pre- and post-enrollment surveys.
II. Evaluate implementation of survivorship best practices into clinical practice and documentation after enrollment in our Survivorship ECHO.
OUTLINE:
Participants attend 6 sessions of Survivorship ECHO educational intervention over 1 hour each, every 2 weeks for 12 weeks. Participants may optionally participate in a one-on-one interview to give feedback about the sessions over 30 minutes.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Health services research (Survivorship ECHO) | Experimental | Other: Educational Intervention, Other: Interview, Other: Survey AdministrationParticipants attend 6 sessions of Survivorship ECHO educational intervention over 1 hour each, every 2 weeks for 12 weeks. Participants may optionally participate in a one-on-one interview to give feedback about the sessions over 30 minutes. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Providers from The James Cancer Network (consists of five community sites in Ohio: St. Rita's Memorial Center, Memorial Health, Madison Health, Wooster Community Hospital, and Clinton Memorial Hospital)
- Eligible participants will include registered nurses, advanced practice registered nurses, physician assistants, nutritionists, radiation oncologists and oncologists
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Educational InterventionAlso: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, EducationalReceive educational intervention | Other | Health services research (Survivorship ECHO) |
| InterviewParticipate in one-on-one interview | Other | Health services research (Survivorship ECHO) |
| Survey AdministrationAncillary studies | Other | Health services research (Survivorship ECHO) |
Primary outcome
Change in level of understanding in key survivorship knowledge areas
Time frame: Baseline up to study completion, typically 1 year
Includes knowledge on surveillance, late and long-term effects of chemotherapy, health promotion, disease prevention and psychosocial evaluation and support. A Likert survey will assess provider comfort and knowledge with core cancer survivorship competencies with higher scores associated with higher levels of knowledge and comfort.
Met and unmet needs
Time frame: Up to study completion, typically 1 year
Content, participant needs, and aspects of delivering the Survivorship ECHO platform explored using qualitative analysis.
Acceptability of current structure
Time frame: Up to study completion, typically 1 year
Content, participant needs, and aspects of delivering the Survivorship ECHO platform explored using qualitative analysis.
Barriers to accessing ECHO
Time frame: Up to study completion, typically 1 year
Content, participant needs, and aspects of delivering the Survivorship ECHO platform explored using qualitative analysis.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Dec 2025.
- The JameslineLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Hematopoietic and Lymphoid Cell Neoplasm
RecruitingPhase 1
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
RecruitingPhase 1/2
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Acute Myeloid Leukemia, Acute Lymphoid Leukemia
RecruitingPhase 1
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Malignancy, Hematologic, Neoplasms, Hematologic
Active, not recruiting
The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Active, not recruitingObservational study
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
Waldenstrom Macroglobulinemia, Chronic Lymphocytic Leukemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ashley Davenport, MD principal investigator
Ohio State University Comprehensive Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Educational Intervention, Interview and Survey Administration in people with Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, run by Ohio State University Comprehensive Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in level of understanding in key survivorship knowledge areas (time frame: Baseline up to study completion, typically 1 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2025.